Trial Profile
A Phase Ib/IIa Single Centre, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Dose Ranging Trial in Adult Participants With Uncomplicated Dengue Fever in Singapore
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Modipafant (Primary) ; Celgosivir
- Indications Dengue
- Focus Therapeutic Use
- 19 Mar 2020 Planned End Date changed from 1 Sep 2020 to 8 Aug 2019.
- 19 Mar 2020 Planned primary completion date changed from 1 Sep 2020 to 8 Aug 2019.
- 19 Mar 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.